Literature DB >> 16857956

Clopidogrel pharmacogenetics: promising steps towards patient care?

Amber L Beitelshees, Howard L McLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16857956     DOI： 10.1161/01.ATV.0000232583.51472.73

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  5 in total

1.  The investigation of allele and genotype frequencies of CYP3A5 (1/3) and P2Y12 (T744C) in Iran.

Authors:  N Azarpira; S Namazi; A Khalili; M Tabesh
Journal:  Mol Biol Rep       Date:  2010-12-14       Impact factor: 2.316

Review 2.  Antithrombotic therapies in primary angioplasty: rationale, results and future directions.

Authors:  Giuseppe De Luca; Paolo Marino
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

4.  Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system.

Authors:  Samuel G Johnson; Paul B Shaw; Thomas Delate; Deanna L Kurz; Dylon Gregg; John C Darnell; Christina L Aquilante
Journal:  Pharm Pract (Granada)       Date:  2017-06-30

5.  Platelet Function Analyzer-200 P2Y Results Are Predictive of the Risk of Major Adverse Cardiac Events in Korean Patients Receiving Clopidogrel Therapy Following Acute Coronary Syndrome.

Authors:  Hyeon Ho Lim; Shuhua Li; Gyu Dae An; Kwang Sook Woo; Kyeong Hee Kim; Jeong Man Kim; Moo Hyun Kim; Jin Yeong Han
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.